Standardization of ~(131)I treatment for patients with differentiated thyroid cancers after thyroidectomy
10.19538/j.cjps.issn1005-2208.2019.03.06
- Author:
Han-kui LU
1
Author Information
1. Department of Nuclear Medicine, Shanghai Sixth Hospital of Shanghai Jiaotong University Shanghai 201101,China
- Publication Type:Journal Article
- Keywords:
differentiated thyroid cancer;
radioisotope ~(131)I
- From:
Chinese Journal of Practical Surgery
2019;39(03):213-215
- CountryChina
- Language:Chinese
-
Abstract:
Standardization of ~(131)I treatment following thyroidectomy for DTC patients tends to be compulsory in clinical practice. However, many remains controversies concerning with the indications for ~(131)I treatment since it takes definitive effects mostly in parts of DTC patients with unresectable lesions or metastases. Standardization of ~(131)I treatment also requires proper management of radiation protection for in-patients taking high dose ~(131)I,objective and complete evaluation of treatment outcomes as well as side effects related with ~(131)I therapy, and above all, the establishment of long-term follow-up database.
